The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 08, 2021

Filed:

Sep. 24, 2015
Applicants:

Sapporo Medical University, Sapporo, JP;

Medical & Biological Laboratories Co., Ltd., Aichi, JP;

Inventors:

Toshihiko Torigoe, Sapporo, JP;

Eri Atsuyama, Nagano, JP;

Hironori Otaka, Nagano, JP;

Kazue Nakano, Nagano, JP;

Dongliang Li, Nagano, JP;

Shingo Toji, Nagano, JP;

Takuya Asano, Sapporo, JP;

Ryota Horibe, Sapporo, JP;

Yoshihiko Hirohashi, Sapporo, JP;

Noriyuki Sato, Sapporo, JP;

Tsuyoshi Saito, Sapporo, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/17 (2015.01); C12N 5/0783 (2010.01); C07K 14/47 (2006.01); C12N 15/63 (2006.01); A61K 48/00 (2006.01); C12N 15/09 (2006.01); A61K 35/76 (2015.01); C12N 15/00 (2006.01); C12N 5/10 (2006.01); A61K 39/00 (2006.01); C07K 7/06 (2006.01); C07K 14/74 (2006.01); C07K 16/18 (2006.01); C07K 16/30 (2006.01); C12N 5/078 (2010.01); G01N 33/574 (2006.01); C07K 14/82 (2006.01);
U.S. Cl.
CPC ...
C07K 14/4703 (2013.01); A61K 35/76 (2013.01); A61K 39/00 (2013.01); A61K 39/0011 (2013.01); A61K 48/00 (2013.01); C07K 7/06 (2013.01); C07K 14/70539 (2013.01); C07K 16/18 (2013.01); C07K 16/30 (2013.01); C12N 5/0634 (2013.01); C12N 5/0638 (2013.01); C12N 5/10 (2013.01); C12N 15/00 (2013.01); C12N 15/09 (2013.01); G01N 33/57496 (2013.01); A61K 2039/5158 (2013.01); A61K 2039/572 (2013.01); C07K 14/82 (2013.01); C12N 2510/00 (2013.01); G01N 2333/4704 (2013.01);
Abstract

The object is to provide a tumor antigen peptide that is specifically presented on a cancer and a cancer stem cell, and a pharmaceutical composition, etc. that is useful for the prevention and/or treatment of a cancer and contains the above peptide as an active ingredient. The above object has been accomplished by providing a BORIS-derived partial peptide belonging to isoform A or C or subfamily 5 or 6, a polynucleotide encoding the peptide, a pharmaceutical composition containing the above as an active ingredient, and an agent for the prevention and/or treatment of a cancer, the agent containing the above as an active ingredient and inducing CTLs.


Find Patent Forward Citations

Loading…